Amidst the surging drug costs in Canada, it’s essential for employers to meticulously assess their pharmacy benefit plan and the frequency of reviewing drug plan costs with their benefits broker. Understanding the underlying cost drivers is equally important. Our local and international partners’ expertise can help devise a multi-year strategy to counter growing drug expenses, safeguarding your finances and employee well-being. Let’s collaborate to create a cost-effective solution for essential drug treatments.
In 2018, Canadians spent approximately $33 billion on prescribed drugs, with over half of this expense being borne by private companies and individuals. This upward trend in pharmaceutical costs underscores the urgency for employers to thoroughly evaluate their pharmacy benefit plans. Let ReFrame’s partners proactively manage rising pharmaceutical expenses and ensure your employees have access to vital treatments without compromising your bottom line.
Understanding your business and your vision for its future enables us to effectively evaluate your current benefits offering. We conduct relevant market analysis and research, observing trends and emerging best practices to ensure we find the right fit for your company.
By combining our research, experience and key insights into your business, we are able to design a group benefits solution that supports your culture, strategic objectives and drives employee engagement. You then have complete freedom to further customize any aspect of the plan.
When implementing changes to people-based programs, it’s easy to overlook change readiness, which can have adverse impacts despite best intentions. We guarantee implementation is supported through communication and understanding that respects all stakeholders and groups.
We deliver on our client promises. Our ongoing partnership with you allows us to identify critical success factors and create a quality assurance and service program that supports your specific needs.
